The FDA is approving the first needle-free alternative to the EpiPen. It's a single-use nasal spray to treat allergic reactions in emergencies. "Neffy" from ARS Pharmaceuticals can be used in adults and some children. The FDA says this may alleviate the fear of injections making neffy "an important treatment option." The drug was expected to be approved last year, but more info on repeat dosing was needed.